Gregory Raskin, VP of Memorial Sloan Kettering, has been asked by the hospital to turn over nearly $1.4 million in profits garnered from a "windfall stake" in a biotech company, in today's bite-sized hospital and health industry news from Florida, Massachusetts, Nebraska, and New York.
In Texas, dozens of patients are taking legal action after receiving a botched compounded injectable eye drug that left them partially blind—a case that observers say highlights the holes in regulatory oversight of compounding pharmacies, Stephanie Lee reports for BuzzFeed News.
A Harvard Medicine School professor says patients shouldn't 'reflexively' call an ambulance when alternatives such as Uber and Lyft are available, Austin Frakt writes for the New York Times' 'The Upshot.'
The Royal Swedish Academy of Sciences is awarding the 2018 Nobel Prize in Chemistry to three scientists who applied evolutionary principles to the field to produce new proteins that spurred the development of treatments for autoimmune diseases and cancer.
Hospital and other industry groups say CMS' proposed update to Medicare's Hospital Outpatient and Ambulatory Surgical Center Payment Systems for calendar year 2019 could inhibit patients' access to care.
The ranking of a doctor's medical school has little to no relation to the provider's patient mortality and readmissions rates, according to a study published in The BMJ.
